72 related articles for article (PubMed ID: 77217)
61. [Treatment of prostatic carcinoma with phostrolin and bromocriptine while monitoring serum concentrations of testosterone and prolactin].
Jeromin L
Pol Tyg Lek; 1980 Mar; 35(10):359-62. PubMed ID: 7367321
[No Abstract] [Full Text] [Related]
62. Clinical trial of 2-bromo-alpha-ergocryptine (NSC-169774) in human prostatic cancer.
Coune A; Smith P
Cancer Chemother Rep; 1975; 59(1):209-13. PubMed ID: 1093667
[TBL] [Abstract][Full Text] [Related]
63. [Bromocriptine, a new therapeutic principle in prostatic adenoma and carcinoma. Basis, possibilities, limits].
Jacobi GH; Altwein JE
Dtsch Med Wochenschr; 1978 May; 103(19):827-33. PubMed ID: 77217
[No Abstract] [Full Text] [Related]
64. [Prolactin and cancer of the prostate. IV. Prolactin inhibition in the treatment of prostatic cancer].
Maganto Pavón E; Mayayo Dehesa T; Mateos Torres JA; Boronat Tormo F; Verdú Tartajo F; de Blas Gómez V
Arch Esp Urol; 1982; 35(5):312-25. PubMed ID: 6758710
[No Abstract] [Full Text] [Related]
65. [Relation of prolactin with nodular hyperplasia and carcinoma of the prostate].
Romero L; Muñoz C; López A; Vilches J
Actas Urol Esp; 1991; 15(6):503-9. PubMed ID: 1724345
[TBL] [Abstract][Full Text] [Related]
66. Prolactinoma and bromocriptine therapy.
Skaf RA
N J Med; 1986 Jul; 83(7):455-60. PubMed ID: 3528940
[No Abstract] [Full Text] [Related]
67. [Botulinic toxin of type A in the treatment of prostatic adenoma and cancer].
Mazo EB; Krivoborodov GG; Shkol'nikov ME; Efremov NS
Urologiia; 2008; (4):63-6. PubMed ID: 19058365
[No Abstract] [Full Text] [Related]
68.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
69.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
70.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
71.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
72.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
